Ever Fortune.AI Co., Ltd.

6841

TW0006841000

IT Services & Consulting

End-of-day quote Taipei Exchange Other stock markets 03:30:00 28/05/2024 am IST			5-day change	1st Jan Change
84.2 ^TWD	+0.84%		+0.48%	-12.75%

24/05	Ever Fortune.AI Co., Ltd. Announces Board Changes	CI
24/05	Ever Fortune.AI Co., Ltd. Announces Cash Dividend for the Year 2023 Payable on June 28, 2024	CI

Singapore H.S.A Approves EFAI Cardiosuite SPECT Myocardial Perfusion Agile Workflows of Ever Fortune.Ai Co., Ltd

April 22, 2024 at 01:50 pm IST

Ever Fortune.AI Co., Ltd. announced approval of EFAI Cardiosuite SPECT Myocardial Perfusion Agile Workflows by Singapore H.S.A. EFAI Cardiosuite SPECT Myocardial Perfusion Agile Workflows is an image processing software that provides analysis on DICOM.

Latest news about Ever Fortune.AI Co., Ltd.

Ever Fortune.AI Co., Ltd. Announces Board Changes	24/05	CI
Ever Fortune.AI Co., Ltd. Announces Cash Dividend for the Year 2023 Payable on June 28, 2024	24/05	CI
Ever Fortune.AI Co., Ltd. Approves Change of Registered Business Address	07/05	CI
Singapore H.S.A Approves EFAI Cardiosuite SPECT Myocardial Perfusion Agile Workflows of Ever Fortune.Ai Co., Ltd	22/04	CI
Ever FEver Fortune.AI Co., Ltd. Announces U.S.FDA Approves EFAI Cardiosuite CTA AcuteAortic Syndrome Assessment System (EFAI AASCTA)	09/04	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/23/14	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	31/23/31	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	11/22/11	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	11/22/11	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	14/22/14	CI
Ever Fortune.AI Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/22/25	CI
Ever Fortune.AI Co., Ltd.(TPEX:6841) added to S&P Global BMI Index	21/22/21	CI

Chart Ever Fortune.AI Co., Ltd.

Duration

Period

More charts

Company Profile

Ever Fortune. AI Co Ltd is a Taiwan-based company mainly engaged in the research, development, manufacture and sale of medical artificial intelligence software related products. The Company mainly provides medical big data and cloud biomedical platform, medical artificial intelligence (AI) technology solutions. The Company provides medical artificial intelligence data, analysis technology and services, and customized medical AI technology solutions. The Company's products include radiographic bone age-assisted interpretation and height prediction system, ultrasound breast tumor auxiliary classification system, computer tomography liver cancer metastasis risk management system, liver fibrosis evaluation system, and irregular cardiac fibrillation interpretation.

Sector

IT Services & Consulting

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

84.2 TWD

Average target price

130 TWD

Spread / Average Target

+54.39%

Consensus

Sector Other IT Services & Consulting

	1st Jan change	Capi.
EVER FORTUNE.AI CO., LTD.	-12.75%	252M
ACCENTURE PLC	-15.49%	189B
TATA CONSULTANCY SERVICES LTD.	+1.23%	167B
IBM	+3.35%	157B
AUTOMATIC DATA PROCESSING, INC.	+4.10%	102B
CROWDSTRIKE HOLDINGS, INC.	+35.93%	85.01B
RELX PLC	+10.16%	83.93B
INFOSYS LIMITED	-4.92%	73.3B
SNOWFLAKE INC.	-24.47%	52.32B
HCL TECHNOLOGIES LIMITED	-7.35%	44.09B

Other IT Services & Consulting

Ever Fortune.AI Co., Ltd.

Equities

6841

TW0006841000

IT Services & Consulting

Singapore H.S.A Approves EFAI Cardiosuite SPECT Myocardial Perfusion Agile Workflows of Ever Fortune.Ai Co., Ltd

Latest news about Ever Fortune.AI Co., Ltd.

Chart Ever Fortune.AI Co., Ltd.

Company Profile

Income Statement Evolution

Analysts' Consensus

Sector Other IT Services & Consulting